Billionaire Larry Robbins’ 5 Dividend Stock Picks

1. CVS Health Corporation (NYSE:CVS)

Glenview Capital’s Stake Value: $588,694,104

On June 4, Morgan Stanley raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $111 from $106. It reiterated an Overweight rating on the shares. The analyst noted that managed care stocks have been “grinding higher” as signs of softer utilization trends begin to emerge. Morgan Stanley also examined the potential impact of artificial intelligence on managed care organizations, saying AI could support both revenue growth and cost reductions. According to the firm, those efficiencies could eventually generate about 45% average EPS upside as they scale over time.

On June 8, Mizuho raised its price goal on CVS to $115 from $110. It kept an Outperform rating on the stock. The firm believes the managed care sector is moving into a “more stable and predictable” policy environment. In a research note, the analyst said the magnitude and frequency of policy-related surprises are likely to ease from the elevated levels seen over the past three years. That shift could allow investors to focus more on company fundamentals, pricing recovery, and the sector’s underlying earnings power. Mizuho also increased price targets across the sector to reflect what it views as a more stable regulatory and legislative backdrop.

CVS Health Corporation (NYSE:CVS) is a health solutions company. Its operations are organized into four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other.

READ NEXT: 10 Best S&P 500 Dividend Stocks to Buy Right Now and 10 Best Value Dividend Stocks to Buy Now According to Warren Buffett

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.